Home > Press > NVE Notified of Grant of Two Patents Related to Laboratory-on-a-Chip Technology
NVE Corporation (Nasdaq:NVEC) announced today that it has been notified by the U.S. Patent and Trademark Office of the expected grant of two patents relating to "laboratory-on-a-chip" technology.
NVE Notified of Grant of Two Patents Related to Laboratory-on-a-Chip Technology
EDEN PRAIRIE, MN | Posted on June 26th, 2007
The company has been notified that patent number 7,235,969, titled "Thin-Film Structure Magnetizable Bead Detector," will issue today and that patent number 7,238,539, titled "Magnetizable Bead Detector," will issue July 3, 2007.
In proposed laboratory-on-a-chip systems, magnetic biological marker nano-beads adhere to an immobilization surface when a targeted biological agent is present. Spintronic biosensors detect magnetic perturbations from the nano-beads to detect and quantify the presence of very low levels of biological or chemical materials.
The grants will bring NVE's U.S. patent total to 44. The company has more than 100 patents worldwide issued, pending, or licensed from others. Links to the new patent and NVE's other U.S. patents can be found at the "About NVE" section of the company's Website ( http://www.nve.com ).
About NVE Corporation
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
The NVE Corporation logo is available at
Statements used in this press release that relate to future plans, events, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to the grant of patents in the future, risks in the enforcement of our patents, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K and other reports filed with the SEC.
For more information, please click here
Curt A. Reynders
Chief Financial Officer
Copyright © PrimeNewswire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014
Relieving electric vehicle range anxiety with improved batteries: Lithium-sulfur batteries last longer with nanomaterial-packed cathode April 16th, 2014
Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014
Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014